Primary study of seroprevalence to virus pathogens in wild felids of South Primorie, Russia

Canadian Journal of Zoology, e-First Articles. Seroprevalence to nine different virus pathogens was estimated for Russian big cats (Amur tiger (Panthera tigris altaica Temminck, 1844) and far-eastern leopard (Panthera pardus orientalis (Schiegel, 1857))) in Southern Primorie, Russia (n = 25), in 2008 –2016. Serum samples from smaller cats (Eurasian lynx (Lynx lynx (Linnaeus, 1758)) and far-eastern wildcat (leopard cat) (Prionailurus bengalensis euptilurus (Elliot, 1871))) were also tested for these pathogens (n = 19) during the same period. Felids of Russian Southern Primorie showed seropreval ence to eight out of nine tested pathogens, including highly dangerous feline immunodeficiency virus, feline leukemia virus, and canine distemper virus. Antibodies to feline panleukopenia virus were found to be much more widespread in cats (45%) than antibodies to any other virus. They were detected in samples taken from tigers, leopards, and far-eastern wildcats but not lynxes. Antibodies to pseudorabies virus were detected only in Amur tiger (29%), whose main prey is the most common carrier of the virus (wild boar), unlike for the other studied cats’ species.
Source: Canadian Journal of Zoology - Category: Zoology Authors: Source Type: research

Related Links:

AbstractThe distribution ofBCR –ABL1 transcript variants e13a2 ( “b2a2”) and e14a2 (“b3a2”) in Nigerians with chronic myeloid leukemia (CML) had not been previously studied. In addition, there is paucity of data on the impact ofBCR –ABL1 transcript variants on clinical presentation and survival in CML patients in Nigeria. TheBCR –ABL1 transcript variants were analyzed in 230 Imatinib-treated CML patients at diagnosis. Patients with incomplete data (n  = 28), e19a2 (n = 3) and e1a2 (n = 1) were excluded from analysis of transcript variant on...
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research
Publication date: Available online 24 February 2020Source: Life SciencesAuthor(s): Fei-Yan Xiao, Zhi-Ping Jiang, Fang Yuan, Fang-Jiao Zhou, Wei Kuang, Gan Zhou, Xiao-Ping Chen, Rong Liu, Hong-Hao Zhou, Xie-Lan Zhao, Shan CaoAbstractBackgroundNQO1 protein acts as a cellular protective system, on account of its role as a quinone reductase and redox regulator. Nonetheless, new NQO1 roles are emerging—including its regulation of the cellular proliferation of many tumor cells—and this enzyme has been found to relate to the incidence of various diseases, including chronic myeloid leukemia. However, the mechanisms thr...
Source: Life Sciences - Category: Biology Source Type: research
Conditions:   Acute Leukemia;   Myelodysplastic Syndrome Interventions:   Procedure: Hematopoietic Cell Transplantation;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Tomotherapy;   Radiation: Total-Body Irradiation;   Radiation: Volume Modulated Arc Therapy Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Plasma Cell Myeloma Interventions:   Behavioral: The DISCO App;   Behavioral: Usual Care Sponsor:   Barbara Ann Karmanos Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Myeloid Leukemia;   Essential Thrombocythemia;   Myelodysplastic Syndrome;   Myelodysplastic/Myeloproliferative Neoplasm;   Myeloproliferative Neoplasm;   Myeloproliferative Neoplasm, Unclassifiable;   Polycythemia Vera;   Primary Myelofibrosis;   Secondary Myelofibrosis Interventions:   Drug: Decitabine;   Drug: Ruxolitinib;   Drug: Fedratinib Sponsors:   University of Washington;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hematologic Diseases;   Hematologic Malignancy;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia Interventions:   Device: CliniMACS;   Procedure: Bone Marrow Transplant;   Drug: Hyperfractionated Total Body Irradiation;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Busulfan;   Drug: Melphalan;   Drug: Fludarabine Sponsor:   Baptist Health&nb...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Follicular Lymphoma;   Marginal Zone Lymphoma;   Mantle Cell Lymphoma;   Diffuse Large B Cell Lymphoma;   Advanced Solid Tumor;   Non-small Cell Lung Cancer;   Metastatic Melanoma Interventions:   Drug: BGB-10188;   Drug: Zanubrutinib;   Drug: Tislelizumab Sponsor:   BeiGene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Plasma Cell Myeloma Interventions:   Behavioral: The DISCO App;   Behavioral: Usual Care Sponsor:   Barbara Ann Karmanos Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Myeloid Leukemia;   Essential Thrombocythemia;   Myelodysplastic Syndrome;   Myelodysplastic/Myeloproliferative Neoplasm;   Myeloproliferative Neoplasm;   Myeloproliferative Neoplasm, Unclassifiable;   Polycythemia Vera;   Primary Myelofibrosis;   Secondary Myelofibrosis Interventions:   Drug: Decitabine;   Drug: Ruxolitinib;   Drug: Fedratinib Sponsors:   University of Washington;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hematologic Diseases;   Hematologic Malignancy;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia Interventions:   Device: CliniMACS;   Procedure: Bone Marrow Transplant;   Drug: Hyperfractionated Total Body Irradiation;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Busulfan;   Drug: Melphalan;   Drug: Fludarabine Sponsor:   Baptist Health&nb...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Canada Health | Leukemia | Russia Health | Study | Zoology